ribosomes from both species are grossly similar, there but the erythromycin affinity increases by more than are surprising differences in detail. The conformations 10 4 -fold, implying that desolvation of the N2 of G2099 of many of these antibiotics as well as their interactions with the surrounding ribosomal structure are in many accounts for the low wild-type affinity for macrolides.
Even though the G2058A mutation greatly increases 1993) and sequence information about H. marismortui (Hma) posted on the web by the DasSarma group the affinity of Hma ribosomes for macrolides, the location and conformation of the macrolide rings bound to ([http://zdna2.umbi.umd.edu], Hma contigs version 2), strains of Hma were produced that contain either muthese ribosomes are only slightly different from those bound to wild-type large subunits from the same organtated 23S rRNA genes or a mutated L22 gene (D.T., G.B., P.B.M., and T.A.S., unpublished data). In many of ism (Hansen et al., 2002a ) and thus still differ markedly from those reported for macrolide complexes with the these experiments, G2099A large subunits were prepared from a strain containing two native rRNA operons Dra subunit (Berisio et al., 2003; Schlü nzen et al., 2001). Thus, the differences in the models reported for macroand a single mutant rRNA operon, and hence the ratio of large subunits containing the G2099A mutation to lide antibiotics bound to Hma and Dra cannot be attributed to the sequence difference at position 2058.
wild-type large subunits was w1:2. A few experiments were done using large ribosomal subunits prepared The conformation of L22 containing the deletion that causes resistance differs from its conformation in wildfrom strains in which the ratio of mutant to wild-type 23S rRNA cistrons was either w1:1, or only a single, type large ribosomal subunits. The loop of L22 bends away from the tunnel wall, widening the gap between mutated 23S rRNA cistron was present. Southern blots and DNA sequencing of polymerase chain reaction L22 and L4, but no structural change is observed in the region where erythromycin binds. These observations products confirmed the presence of the expected number of rRNA operons in each strain and the identities of rationalize the chemical protection data reported earlier for such mutants in E. coli (Gregory and Dahlberg, the bases at position 2099. RNA sequencing demonstrated that A2099 and G2099 containing 23S rRNA 1999) but provide only hints as to why these ribosomes are less sensitive to inhibition by erythromycin. (Unless cistrons are produced in strains containing both kinds of genes. The large ribosomal subunits obtained from otherwise stated, in the text that follows, nucleotide or protein residue numbering will refer to Hma, not E. coli, these strains crystallize under the same conditions as wild-type Hma large ribosomal subunits to produce isobut the equivalent number in E. coli will be given in parentheses.) morphous crystals (Ban et al., 2000). (F o (mutant + drug) − F o (wild-type − drug)) difference hydroxyl and two axially oriented carbonyl oxygens. In contrast, the face of the lactone ring that contacts the electron density map calculated at 2.75 Å resolution using data from this crystal ( Figure 1A ) clearly showed tunnel wall is hydrophobic. It contains no hydrogen bond donors or acceptors, but it does include three the conformation and orientation of the bound drug.
Erythromycin lies on the floor of nascent peptide tunmethyl groups that insert into the hydrophobic pocket formed by base of A2100 (A2059), the hydrophobic, C2 nel with the edges of its two sugars pointing toward the ribosomal A and P sites. The 2#OH of its desosamine edge of A2099 (A2058), and the base and sugar of G2646 (C2611) ( Figure 2C ). The snug fit of this face of sugar forms a hydrogen bond with the N1 of A2099 (2058). The side of its lactone ring facing the lumen of erythromycin with the tunnel wall would be altered both sterically and chemically by addition of a hydrophilic the tunnel is hydrophilic. It includes two axially oriented The presence of the G2099A subunits in these crysdata sets. To determine the concentration at which the occupancy of the drug began to diminish, difference tals is clearly evident in difference electron density maps. Figure 2A shows the relevant portion of an unbiFourier maps were also calculated between data sets from crystals containing different drug concentrations. ased difference electron density map calculated using (F o (mutant + drug) − F o (wild-type − drug)) amplitudes Since crystals used in this titration experiment were all from the same batch of subunits, it was not necessary and wild-type, apo phases. The mutant crystals used contained w33% G2099A large subunits and were to establish the exact fraction of mutant subunits; it was the same in all crystals. highly isomorphous to the wild-type crystals to which they are compared. In addition to positive electron denWhile the difference map between crystals of wildtype subunit soaked in 3 mM erythromycin and native sity for erythromycin, this map includes a negative 4 σ peak at the position occupied by the N2 of G2099 in showed no convincing difference density, the corresponding map using data from the 33% G2099A crystal the wild-type large subunit (Figure 2A) , proving that the nucleotide at position 2099 is an A in the mutant large soaked in 3 M erythromycin showed full density for the bound drug at a contour level of 3.5 σ ( Figure 2B ). subunits.
A lower-bound estimate of the change in the binding The same native data set was used for calculating both difference maps, and the cross-R factors between each affinity of the Hma large ribosomal subunit for erythromycin afforded by the G2099A mutation was obtained of the two data sets from the crystals soaked in drug and the same native data set are essentially identical. by a crystallographic titration. Erythromycin was soaked into crystals containing 33% G2099A subunits at con- Figure 3A ). The 2OH of its galactose moiety mycin complex) − F o (native)) amplitudes was clear, the hydrogen bonds to the N1 of A2099, and 3OH forms contour level had to be lowered to 2.5 σ, and the differhydrogen bonds with the N6 of A2099 and the nonence map calculated between data obtained from crysbridging phosphate oxygen of G2540 (G2505). In additals soaked in 1 M erythromycin and those soaked in 3 tion, the 4OH of its galactose moiety hydrogen bonds M erythromycin showed negative density for the drug.
to the 2#OH of A2538 (A2503) and N6 of A2100 (A2059), Thus, as the erythromycin concentration drops from 3 and the nitrogen atom of the peptide bond linking its M to 1 M, its occupancy in these crystals drops apgalactose moiety to its pyrrolidine group forms a hypreciably. The dissociation constant, however, could be drogen bond with the 2#OH of G2540 (G2505). beginning of the peptide exit tunnel at a site that overTelithromycin laps those occupied by both A-and P-site substrates, Telithromycin is a semisynthetic derivative of erythroas it does in wild-type Hma large ribosomal subunits mycin in which the cladinose sugar linked to C3 of the (Hansen et al., 2003) . Its largely hydrophobic macrolactone ring of erythromycin is replaced by a keto cyclic lactone ring fits tightly over hydrophobic base group, the hydroxyl group at C6 is methylated, and the planes of A2486 (A2451) and G2102 (G2061). Its C2 iso-C11/C12 position is extended by a carbamate N substipropyl group is inserted underneath the base of U2620 tuted with an alkyl chain that ends in two aromatic het-(U2585), forming a favorable stacking interaction, and erocycles. We have established the structure of telithroits hydroxyl group at C13 forms a hydrogen bond with mycin bound to 33% G2099A crystals ( Figure 1B In its overall conformation, virginiamycin S looks like a to G2099A large ribosomal subunits has been detercup, with its phenyl and pyrrolidine rings stacked on mined at a resolution of 3.00 Å ( Table 1) The S component also makes some hydrophobic contacts with the ribosome. The phenyl residue in C3 of the virginiamycin S lactone ring stacks onto the ribose moiety of C2644 (U2609) and thereby displaces its base by about 45°compared to the native structure of the large subunit. An additional stacking interaction is observed between the aliphatic stretch of C17 to C19 onto the base of pseudouridine 2621 (U2586).
Binding of virginiamycin S to the large subunit is also stabilized by metal ion interactions. A magnesium ion coordinates the hydroxyl and carbonyl oxygens of the conjugated [(3-hydroxy-2-pyridinyl)carbonyl] amino group from C18 of the drug. The octahedral coordination of this magnesium ion is completed by four additional water molecules of which one is in hydrogen bond distance to a nonbridging phosphate oxygen of C2476.
The Effect of G2099A Mutations on Virginiamycin S Binding
The occupancies of the virginiamycin M and S sites in these mixed mutant and wild-type crystals are about the same, which implies that under these conditions, it makes no difference whether large subunits have an A or a G at position 2099. This was not entirely unexpected because in E. coli, A2058U mutants do not bind virginiamycin S, but in the presence of virginiamycin M, high-affinity binding of virginiamycin S occurs (Vannuffel et al., 1992). Knowing virginiamycin S binds to both the G2099 or A2099 50S subunit in the presence of virginiamycin M, residue 2099 was modeled as a G during refinement. The N2 of G2099 in the refined structure is 3.0 Å from the closest atom in the C9 benzyl group of virginiamycin S. This juxtaposition should destabilize the binding of virginiamycin S and may explain why A2058G (E. coli ) mutation confers streptogramin B resistance.
Binding of Virginiamycin S Alone
To gain further insights into the influence of virginiamycin M on virginiamycin S binding, a saturating con- its for dissociation constants is that the rate at which toward the position of the C9 benzyl group caused by ligands diffuse into crystals becomes rate limiting at a need to increase the contribution of the methylated those concentrations and because the total number of amine in stacking.
ligand molecules in the solutions in which crystals are soaked becomes comparable to the number of drug The Structure of the Large Subunit binding sites in the crystals. Therefore, it is probable Containing an L22 Mutant that the erythromycin dissociation constant of G2099A The three amino acid deletion (122-124) in L22 of Hma large ribosomal subunits from Hma is substantially less is equivalent to the deletion mutation in E. coli that rethan the data presented here appear to document, i.e., moves Met82, Lys83, and Arg84 from the conserved <1 M. Thus, even though we cannot exclude the pos-C-terminal β hairpin of L22 from E. coli and confers sibility that the erythromycin dissociation constant of erythromycin resistance to E. coli ribosomes without re-G2099A Hma large subunits might still be 100-fold ducing their affinity for the drug (Chittum and Champgreater than that reported for E. coli ribosomes, w0.01 ney, 1994; Wittmann et al., 1973). The structure of large M (Pestka, 1974) , the large size of the decrease in subunits containing this mutation was solved at a resodissociation constant the data support gives us confilution of 2.90 Å ( Table 1) .
dence that the MLSK antibiotic/Hma large subunit strucThe three residue deletion from Hma L22 causes its tures reported here are pharmacologically relevant. entire C-terminal β hairpin to move away from its norMacrolides bind to Hma large ribosomal subunits mal interaction with the RNA of the tunnel wall, near containing the G2099A mutation almost exactly the the erythromycin site, and lodge in the lumen of the same way that they bind to wild-type Hma large subpeptide exit tunnel closer to its exit ( Figure 4C 
(A1614), A841(G748), and U840(U747). Residue U840
While it might seem surprising that the large increase moves the furthest and in the mutant fills a location that in erythromycin affinity that accompanies the G2099A is normally occupied by the tip of L22 β hairpin. Howmutation of Hma large subunit is not accompanied by ever, the difference electron density also indicated the significant changes in the ways macrolides bind, a simexistence of another conformation for U840, implying this residue is mobile in the absence of the L22 hairpin. ilar phenomena has already been observed in HIV re- close to the β hairpin of L22 is G2385 (G2351), and it is tered, which explains why these mutations do not alter the affinity of the ribosome for macrolides. However, it so far away (w90 Å) we are not sure what that observation means. Thus, these correlations give us confidence does not explain why they confer macrolide resistance. In the presence of macrolides, ribosomes synthesize that the effect of those L22 deletions is the same in Hma as it is in E. coli.
short peptides rather than full-length proteins, and it has long been believed that this results because macThe structure of the macrolide binding site in Hma subunits containing the L22 deletion mutation is unalrolides prevent the passage of nascent peptides down Hma and Dra large subunits have drug binding sites of the macrolide inhibition, then the alteration in the whose sequences are highly conserved. The structural conformation of L22 we observed should have no effect differences between the models fall into three cateon macrolide phenotype since erythromycin still binds. gories: drug conformation, variation in the positions Recent biochemical data suggest that the steric adopted by drugs of the same class when bound to the block model is incomplete for some macrolides, like ribosome, and differences in proposed drug-ribosome erythromycin. Recent data show that erythromycin ininteractions. The observations described above indiduces dissociation of peptidyl-tRNAs from the ribocate that the differences between the models derived some that carry peptides six, seven, or eight amino for MLS B K antibiotics bound Hma and Dra large subacids long, with seven being the dominant length (Tenunit may not necessarily arise from sequence differson et al., 2003). Using the structure of an Hma large ences between the eubacterial and archaebacterial riribosomal subunit complex with a P-site substrate bosomes. The G2099A (2058) mutation in the Hma (Hansen et al., 2002b) to place the C-terminal residue subunit increases its affinity for erythromycin by the of peptidyl-tRNAs, we have modeled these peptides same amount (at least 10 4 ) as the A2058G mutation in into the tunnel of a large subunit of H. marismortui with the E. coli subunit decreases it. Further, the interactions erythromycin bound. The lumen of the tunnel is not so made by erythromycin in the G2099A mutant Hma ribooccluded by erythromycin that a peptide cannot get some should be nearly identical to those it makes in a past it (Figures 5A and 5B) . Furthermore, the N-terminal eubacterial ribosome since the only other base differresidue of an eight residue long peptide would reach a ence in the binding site between the two species afpoint in the tunnel that is essentially past the drug. It is fects only a nonsequence-specific stacking interaction. hard to see why a nascent peptide that has gotten this Crystal structures for most of the antibiotics defar down the tunnel should not successfully pass scribed here have been previously determined using through its entire length. However, we note that just as the pure compound. The conformations of all these annascent peptides pass the bound macrolide site, they tibiotics when bound to the Hma large subunit are almust negotiate the constriction in the exit tunnel most identical to the conformations they display as formed by the conjunction of loops of L22 and L4 (Figisolated compounds . However, the conformations asure 5B), the part of the tunnel altered by the L22 mutacribed to these same molecules in their complexes with tions that affect macrolide resistance ( Figure 5C ). Perthe Dra large subunit are in many cases very different haps, in the presence of erythromycin, it is difficult for ( Table 2 ). For example, in both its small molecule crystal structure and in our complex, the cladinose sugar of nascent peptides to get through this passage.
erythromycin is in its low-energy chair conformation The structural consequences of this L22 deletion (Stephenson et al., 1997), but in the erythromycin comhave also been studied by cyroelectron microscopy.
plex with large subunit provided by Schlü nzen et al. Gabashvili and coworkers report that in E. coli 70S ribo-(2001) it is in the boat conformation. In addition, in the somes containing the same L22 mutation (Gabashvili et Schlü nzen et al. structure, the cladinose sugar is axial al., 2001), the diameter of the entire upper end of the relative to the 14-membered lactone ring rather than tunnel increases from w20 Å to w26 Å, and they sugbeing equatorial to it, as it is in both our structure and gest that L22 mutants are resistant to macrolides bethe small molecule crystal structure ( Figures 6A and 6E ). cause the lumen of the tunnel has become so large that In the case of clindamycin, the correspondence beit can no longer be obstructed effectively by macrotween the small molecule crystal structure and the lides. The changes we see are smaller and less extenstructure of the dug bound to the Hma large subunit is sive. The diameter of the tunnel expands from w10 Å again very close ( Figure 6C ). Clindamycin consists of a to w19 Å but only in the region where L4 and L22 come pyrrolidinyl group linked to a galactose sugar by a peptogether in the tunnel. Furthermore, as discussed tide bond ( Figure 1G ). In the structure reported by above, the mechanism of L22 resistance is likely to be Schlü nzen et al. (2001), the relationship between the more complex, since macrolides bind to the tunnel entwo rings differs by 180°(cis rather than trans) from that tirely above the region affected by L22 mutations. Gaseen in the small molecule structure ( Figure 6G ). bashvili et al. also suggested that the rRNA walls of the There is no small molecule structure for telithrotunnel become expanded when L22 is mutated this way mycin, but the structure of its close cousin HMR3004 and speculated that RNA structural changes of this squashed into a highly elongated form that is very difof erythromycin in their erythromycin complex structure differs from that they observe for telithromycin by about ferent from the rounded shape it assumes in crystals of pure HMR3004, pure erythromycin, or in any of the 50°( Figure 6K ). Figures 6D and 6H) . tance mutation in question. On the other hand, the resistance of ribosomes to dimethylation of A2058 (E. coli While it is certainly possible that the binding of the MLS B K antibiotics to the Dra ribosome could result in numbering) or its mutation to G can be rationalized by both structures, since both predict steric clashes that conformational alterations, such distortions would cost free energy, which would decrease their affinities for the should destabilize macrolide binding. Furthermore, both the Dra and the Hma structures can explain why ribosome. Thus, the close similarities of the structures of these antibiotics in isolation and bound to the Hma A2058C and A2058U mutations are resistant to macrolides. ribosome seem more plausible than the significant changes in their structures reported for the Dra subIt remains possible that there is a crystallographic explanation for at least some of the differences between unit complexes.
The second area of difference between our results the Hma and Dra antibiotic models and the accuracy problems of the published Dra complexes (e.g., in the and those of Yonath and coworkers is the way drugs of the same chemical class interact with the ribosome. Dra sparsomycin complex there are no sparsomycin atoms closer than 3.9 Å to a ribosome atom, except For example, in our models, all macrolides bind very similarly, with the hydrophobic underside of their lactwo H-bond acceptors that are separated by 3.5 Å [Bashan et al., 2003]). However, since the Dra large subtone rings inserted into the hydrophobic cleft formed by residues A2100 (A2059), A2099 (A2058), and G2646 unit models in the PDB lack protein side chains and the observed structure factors for almost none of the (C2611). In the case of macrolides with the same size lactone rings such as erythromycin and telithromycin, complexes reported are available, an independent analysis of this possibility cannot be done. lactone rings superimpose almost perfectly ( Figure 2E ). This is not the case for the macrolide structures preIn conclusion, the comparison of structures of large ribosomal subunits with an A or G in position 2099 sented by the Yonath group; the lactone rings of these molecules are not modeled in the same location. For (2058) complexed with MLS B K antibiotics enables us to rationalize how A2058G (E. coli ) genotype is linked to example, the orientation of the plane of the lactone ring
